Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 6
2019 14
2020 15
2021 15
2022 16
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean li jun min (151 results)?
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1.
Park S, Bang SY, Kwag D, Lee JH, Kim TY, Lee J, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW, Kim HJ. Park S, et al. Among authors: min gj. Bone Marrow Transplant. 2024 Mar 4. doi: 10.1038/s41409-024-02255-w. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38438648
Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell Lymphoma.
Choi WH, Han EJ, O JH, Choi EK, Choi JI, Park G, Choi BO, Jeon YW, Min GJ, Cho SG; Catholic University Lymphoma Group. Choi WH, et al. Among authors: min gj. Diagnostics (Basel). 2023 Sep 1;13(17):2834. doi: 10.3390/diagnostics13172834. Diagnostics (Basel). 2023. PMID: 37685372 Free PMC article.
Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study.
Jeon Y, Yang DH, Oh SJ, Park JH, Kim JA, Kim SY, Choi CW, Lee WS, Kim IH, Mun YC, Min GJ, Eom KS, Cho SG. Jeon Y, et al. Among authors: min gj. Front Oncol. 2023 Mar 28;13:998014. doi: 10.3389/fonc.2023.998014. eCollection 2023. Front Oncol. 2023. PMID: 37056335 Free PMC article.
A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia.
Bang SY, Park S, Kwag D, Lee JH, Min GJ, Park SS, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW, Kim HJ. Bang SY, et al. Among authors: min gj. Cancers (Basel). 2023 Mar 8;15(6):1666. doi: 10.3390/cancers15061666. Cancers (Basel). 2023. PMID: 36980551 Free PMC article.
72 results